Acro Biomedical (ACBM) Shareholder's Equity (2015 - 2025)
Acro Biomedical (ACBM) Shareholder's Equity (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shareholder's Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.93 Mn | 477.93 Mn | - | -16.30 Mn |
| 2 | GP-Act III Acquisition | 312.80 Mn | 312.80 Mn | - | -14.48 Mn |
| 3 | Berto Acquisition | 311.56 Mn | 311.56 Mn | - | -12.19 Mn |
| 4 | Churchill Capital Corp IX | 310.79 Mn | 310.79 Mn | - | -11.23 Mn |
| 5 | Centurion Acquisition | 310.21 Mn | 310.21 Mn | - | -13.79 Mn |
| 6 | WEN Acquisition | 309.15 Mn | 309.15 Mn | - | -13.71 Mn |
| 7 | Agriculture & Natural Solutions Acquisition | 303.81 Mn | 303.81 Mn | - | -29.19 Mn |
| 8 | Bold Eagle Acquisition | 274.64 Mn | 274.64 Mn | - | -8.10 Mn |
| 9 | Live Oak Acquisition Corp. V | 265.88 Mn | 265.88 Mn | - | -30.99 Mn |
| 10 | Acro Biomedical | - | - | - | -386,964.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -386,964.00 |
| Sep 30, 2025 | -432,619.00 |
| Jun 30, 2025 | -317,520.00 |
| Mar 31, 2025 | -303,906.00 |
| Dec 31, 2024 | -294,972.00 |
| Sep 30, 2024 | -285,504.00 |
| Jun 30, 2024 | -276,398.00 |
| Mar 31, 2024 | -267,312.00 |
| Dec 31, 2023 | -257,014.00 |
| Sep 30, 2023 | -239,613.00 |
| Jun 30, 2023 | 339,654.00 |
| Mar 31, 2023 | 410,904.00 |
| Dec 31, 2022 | 486,370.00 |
| Sep 30, 2022 | 492,164.00 |
| Jun 30, 2022 | 574,887.00 |
| Mar 31, 2022 | 643,219.00 |
| Dec 31, 2021 | 643,707.00 |
| Sep 30, 2021 | 568,218.00 |
| Jun 30, 2021 | 640,207.00 |
| Mar 31, 2021 | 628,877.00 |